CompoAtlas

PHYTO-BIOPÔLE GINKGO BILOBA

Food supplement declared in France, declaration No 2024-6-67, decision dated 3 June 2024

PHYTO-BIOPÔLE GINKGO BILOBA, from INTERSA LABS S.L., is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Ginkgo biloba 967.7 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
PHYTO-BIOPÔLE
Food business operator placing the product on the market
INTERSA LABS S.L.
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Dropper
Daily dose
0,97 ml
Directions for use
Agiter avant utilisation. Prendre 15 gouttes diluées dans 1/2 verre d'eau, 2-3 fois par jour.
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women, Taking anticoagulants, Taking antidepressants, Taking medication

Declaration 142322, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Ginkgo biloba L.FeuilleExtrait fluide hydroalcoolique967.7 mg

Other ingredients

eau, Alcool

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

NNe pas dépasser la dose journalière recommandée. Les compléments alimentaires ne se substitue pas à une alimentation variée et équilibrée et à un mode de vie sain. Conserver hors de la portée des jeunes enfants. Ne pas utiliser pendant la grossesse ou d'allaitement. Consulter votre médecin en cas d’utilisation simultanée d’anticoagulants. L’emploi chez les personnes sous traitement antidépresseur est déconseillé. Déconseillé en cas d’épilepsie et en cas d’acte interventionnel invasif programmé. Réservé aux adultes. En cas de traitements médicamenteux, demander conseil à un professionnel de santé.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ginkgo biloba L.
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Sources cited by Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : PHYTO-BIOPÔLE

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “PHYTO-BIOPÔLE GINKGO BILOBA: composition and regulation”, https://compoatlas.com/en/supplements/products/142322-phyto-biopole-ginkgo-biloba, updated 15 November 2026.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line